BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36636836)

  • 1. Pre- and Post-treatment Serum BAFF Levels and BAFF Gene Polymorphisms in Patients with Graves' Disease.
    Dhaouadi T; Rojbi I; Ghammouki S; Ben Nacef I; Adel M; Mekni S; Khiari K; Ben Abdallah T; Sfar I; Gorgi Y
    Endocr Res; 2023 Feb; 48(1):16-26. PubMed ID: 36636836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of BAFF gene polymorphisms in UK Graves' disease patients.
    Lane LC; Allinson KR; Campbell K; Bhatnagar I; Ingoe L; Razvi S; Cheetham T; Cordell HJ; Pearce SH; Mitchell AL
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):170-174. PubMed ID: 30281845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases.
    Lin JD; Yang SF; Wang YH; Fang WF; Lin YC; Lin YF; Tang KT; Wu MY; Cheng CW
    PLoS One; 2016; 11(5):e0154436. PubMed ID: 27136204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment.
    Andreou NP; Legaki E; Dovrolis N; Boyanov N; Georgiou K; Gkouskou K; Gazouli M
    Dig Liver Dis; 2021 May; 53(5):574-580. PubMed ID: 33339749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
    Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection.
    Han Q; Yang C; Li N; Li F; Sang J; Lv Y; Zhao W; Li C; Liu Z
    Immunol Lett; 2017 Aug; 188():53-58. PubMed ID: 28627389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females.
    Skarlis C; Papadopoulos V; Raftopoulou S; Mavragani CP; Evangelopoulos ME
    Clin Immunol; 2023 Dec; 257():109847. PubMed ID: 37995946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease.
    Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P
    BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.
    Marín-Rosales M; Cruz A; Salazar-Camarena DC; Santillán-López E; Espinoza-García N; Muñoz-Valle JF; Ramírez-Dueñas MG; Oregón-Romero E; Orozco-Barocio G; Palafox-Sánchez CA
    Clin Exp Med; 2019 May; 19(2):183-190. PubMed ID: 30747361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFSF13B rs9514828 gene polymorphism and soluble B cell activating factor levels: Association with apical periodontitis.
    Cruz A; Gascón LG; Palafox-Sánchez CA; Flores-García C; Espinoza-García N; Sagrero-Fabela N; Cintra LTA; Mejía-Flores R; Salazar-Camarena DC
    Int Endod J; 2023 Apr; 56(4):419-431. PubMed ID: 36508294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients.
    Santillán-López E; Muñoz-Valle JF; Oregon-Romero E; Espinoza-García N; Treviño-Talavera BA; Salazar-Camarena DC; Marín-Rosales M; Cruz A; Alvarez-Gómez JA; Sagrero-Fabela N; Cerpa-Cruz S; Palafox-Sánchez CA
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1950. PubMed ID: 35411715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variants of the
    Flessa CM; Zampeli E; Evangelopoulos ME; Natsis V; Bodewes ILA; Huijser E; Versnel MA; Moutsopoulos HM; Mavragani CP
    Front Immunol; 2022; 13():836824. PubMed ID: 35371038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease.
    Cheng CW; Tang KT; Fang WF; Lin JD
    Eur J Clin Invest; 2019 Jul; 49(7):e13122. PubMed ID: 31034586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.